ZA929317B - Piperazine derivatives - Google Patents
Piperazine derivativesInfo
- Publication number
- ZA929317B ZA929317B ZA929317A ZA929317A ZA929317B ZA 929317 B ZA929317 B ZA 929317B ZA 929317 A ZA929317 A ZA 929317A ZA 929317 A ZA929317 A ZA 929317A ZA 929317 B ZA929317 B ZA 929317B
- Authority
- ZA
- South Africa
- Prior art keywords
- alkyl
- aryl
- hydrogen
- cycloalkyl
- carbon atoms
- Prior art date
Links
- 150000004885 piperazines Chemical class 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- 125000003118 aryl group Chemical group 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- -1 2,3-dihydro-1,4-benzodioxin-5-yl Chemical group 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 150000005840 aryl radicals Chemical class 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919125900A GB9125900D0 (en) | 1991-12-05 | 1991-12-05 | Piperazine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA929317B true ZA929317B (en) | 1994-06-01 |
Family
ID=10705770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA929317A ZA929317B (en) | 1991-12-05 | 1992-12-01 | Piperazine derivatives |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5710149A (fr) |
| EP (1) | EP0625977B1 (fr) |
| JP (1) | JP3262333B2 (fr) |
| KR (1) | KR100244626B1 (fr) |
| AT (1) | ATE162527T1 (fr) |
| AU (1) | AU658242B2 (fr) |
| BR (1) | BR9206861A (fr) |
| CA (1) | CA2124680C (fr) |
| DE (1) | DE69224212T2 (fr) |
| DK (1) | DK0625977T3 (fr) |
| ES (1) | ES2111654T3 (fr) |
| FI (1) | FI942635A (fr) |
| GB (2) | GB9125900D0 (fr) |
| GR (1) | GR3025988T3 (fr) |
| HU (2) | HUT70755A (fr) |
| IL (1) | IL103944A (fr) |
| MX (1) | MX9206939A (fr) |
| NZ (1) | NZ246007A (fr) |
| RU (1) | RU2125566C1 (fr) |
| TW (1) | TW306921B (fr) |
| WO (1) | WO1993011122A1 (fr) |
| ZA (1) | ZA929317B (fr) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9300195D0 (en) * | 1993-01-06 | 1993-03-03 | Wyeth John & Brother Ltd | Piperazine derivatives |
| US5609849A (en) * | 1994-03-11 | 1997-03-11 | The Trustees Of The University Of Pennsylvania | Serotonin (5-HT1A) receptor ligands and imaging agents |
| US5434158A (en) * | 1994-04-26 | 1995-07-18 | Merck & Co., Inc. | Spiro-substituted azacycles as neurokinin-3 antagonists |
| GB9419024D0 (en) * | 1994-09-21 | 1994-11-09 | Wyeth John & Brother Ltd | Bicyclic carboxamides |
| US5607936A (en) * | 1994-09-30 | 1997-03-04 | Merck & Co., Inc. | Substituted aryl piperazines as neurokinin antagonists |
| US5439915A (en) * | 1994-10-20 | 1995-08-08 | American Home Products Corporation | Pyrido[3,4-B]indole carboxamide derivatives as serotonergic agents |
| US5466688A (en) * | 1994-10-20 | 1995-11-14 | American Home Products Corporation | Pyrido[3,4-B]indole derivatives as serotonergic agents |
| US5451584A (en) * | 1994-11-10 | 1995-09-19 | American Home Products Corporation | N-alkynyl carboxamides as sertonergic agents |
| US5541179A (en) * | 1995-05-02 | 1996-07-30 | American Home Products Corporation | Tropon-2-one piperazine carboxamides as serotonergic agents |
| US5990114A (en) * | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
| US5610164A (en) * | 1996-07-24 | 1997-03-11 | American Home Products Corporation | (Thiophen-2-yl)-piperidin or tetrahydropyridin azabicyclocarboxamides |
| US6482827B1 (en) * | 1997-07-10 | 2002-11-19 | Pharmacia & Upjohn S.P.A. | Matrix metalloproteinase inhibitors |
| BR9911280A (pt) * | 1998-06-15 | 2001-03-13 | American Home Prod | Aril piperazinas, piperidinas e tetraidro piridinas substituìdas com ciclo alquila como agentes serotonérgicos |
| US6376494B1 (en) | 1998-06-15 | 2002-04-23 | American Home Products Corporation | Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| US7217714B1 (en) | 1998-12-23 | 2007-05-15 | Agouron Pharmaceuticals, Inc. | CCR5 modulators |
| PE20001420A1 (es) | 1998-12-23 | 2000-12-18 | Pfizer | Moduladores de ccr5 |
| US20060287335A1 (en) * | 2000-11-28 | 2006-12-21 | Wyeth | Serotonergic agents for treating sexual dysfunction |
| US20060223824A1 (en) * | 2000-11-28 | 2006-10-05 | Wyeth | Serotonergic agents |
| JP5080716B2 (ja) | 2001-07-20 | 2012-11-21 | サイコジェニックス・インコーポレーテッド | 注意欠陥・多動性障害の治療 |
| ITMI20021327A1 (it) * | 2002-06-14 | 2003-12-15 | Recordati Chem Pharm | Nuove ossialchilpiperazine |
| US20050215561A1 (en) * | 2004-03-19 | 2005-09-29 | Krishnendu Ghosh | Pharmaceutical dosage forms and compositions |
| US20050209245A1 (en) * | 2004-03-19 | 2005-09-22 | Wyeth | Process for preparing N-aryl-piperazine derivatives |
| US20070099931A1 (en) * | 2004-03-19 | 2007-05-03 | Wyeth | Pharmaceutical dosage forms and compositions |
| JP2008531694A (ja) * | 2005-03-01 | 2008-08-14 | ワイス | 結晶性および非晶性４−シアノ−ｎ−｛（２ｒ）−２−［４−（２，３−ジヒドロ−ベンゾ［１，４］ジオキシン−５−イル）−ピペラジン−１−イル］−プロピル｝−ｎ−ピリジン−２−イル−ベンズアミド塩酸塩 |
| US7731940B2 (en) | 2006-01-25 | 2010-06-08 | The Regents Of The University Of California | Compositions and methods related to serotonin 5-HT1A receptors |
| US9066903B2 (en) | 2006-02-28 | 2015-06-30 | The United States Of America As Represented By The Department Of Veterans Affairs | Pharmacological treatment of Parkinson's disease |
| CA2686926C (fr) * | 2007-05-14 | 2016-01-05 | Sk Holdings Co., Ltd. | Nouveau compose carbamoyloxy arylalcanoyl arylpiperazine, compositions pharmaceutiques comprenant ce compose et methode de traitement de la douleur, de l'anxiete et de la depression comprenant l'administration de ce compose |
| US8367676B2 (en) * | 2009-06-30 | 2013-02-05 | Astrazeneca Ab | 2-carboxamide-7-piperazinyl-benzofuran derivatives 774 |
| US8322764B2 (en) | 2010-06-11 | 2012-12-04 | Mag-Lok Tools, Inc. | Modular long handled tool component system |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK169601B1 (da) * | 1983-10-17 | 1994-12-19 | Duphar Int Res | Piperazinderivater og farmaceutisk præparat indeholdende et sådant derivat, samt piperazinderivater med mellemproduktanvendelse |
| US4788290A (en) * | 1987-12-11 | 1988-11-29 | American Home Products Corporation | Serotonergic pyrazine derivatives |
| GB8909209D0 (en) * | 1989-04-22 | 1989-06-07 | Wyeth John & Brother Ltd | Piperazine derivatives |
| KR0173310B1 (ko) * | 1989-04-22 | 1999-02-01 | 폴 에이 리쳐 | 피페라진 유도체 |
| ATE187718T1 (de) * | 1989-04-22 | 2000-01-15 | American Home Prod | Tertiäre alkyl funktionalisierte piperazin- derivate |
| US5340812A (en) * | 1989-04-22 | 1994-08-23 | John Wyeth & Brother, Limited | Piperazine derivatives |
| US5382583A (en) * | 1989-04-22 | 1995-01-17 | John Wyeth & Brother, Limited | Piperazine derivatives |
| US4935511A (en) * | 1989-09-26 | 1990-06-19 | Rorer Pharmaceutical Corporation | Benzoxazine and benzoxazepine carboxamide 5-HT3 antagonists |
| GB9022820D0 (en) * | 1990-10-19 | 1990-12-05 | Wyeth John & Brother Ltd | Piperazine derivatives |
| GB9022790D0 (en) * | 1990-10-19 | 1990-12-05 | Wyeth John & Brother Ltd | Piperazine derivatives |
| FR2670491B1 (fr) * | 1990-12-14 | 1993-02-05 | Adir | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
| GB9112697D0 (en) * | 1991-06-13 | 1991-07-31 | Shell Int Research | Biocidal compounds |
| FR2692264B1 (fr) * | 1992-06-12 | 1994-08-05 | Adir | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant. |
| GB9308725D0 (en) * | 1993-04-27 | 1993-06-09 | Wyeth John & Brother Ltd | Piperazine derivatives |
-
1991
- 1991-12-05 GB GB919125900A patent/GB9125900D0/en active Pending
-
1992
- 1992-12-01 ES ES92923950T patent/ES2111654T3/es not_active Expired - Lifetime
- 1992-12-01 BR BR9206861A patent/BR9206861A/pt not_active Application Discontinuation
- 1992-12-01 WO PCT/GB1992/002228 patent/WO1993011122A1/fr active IP Right Grant
- 1992-12-01 NZ NZ246007A patent/NZ246007A/en unknown
- 1992-12-01 AT AT92923950T patent/ATE162527T1/de not_active IP Right Cessation
- 1992-12-01 CA CA002124680A patent/CA2124680C/fr not_active Expired - Fee Related
- 1992-12-01 GB GB9225121A patent/GB2262093B/en not_active Expired - Fee Related
- 1992-12-01 RU RU94030476A patent/RU2125566C1/ru active
- 1992-12-01 JP JP50995793A patent/JP3262333B2/ja not_active Expired - Fee Related
- 1992-12-01 AU AU29537/92A patent/AU658242B2/en not_active Ceased
- 1992-12-01 HU HU9401686A patent/HUT70755A/hu unknown
- 1992-12-01 ZA ZA929317A patent/ZA929317B/xx unknown
- 1992-12-01 KR KR1019940701903A patent/KR100244626B1/ko not_active IP Right Cessation
- 1992-12-01 DK DK92923950.7T patent/DK0625977T3/da active
- 1992-12-01 DE DE69224212T patent/DE69224212T2/de not_active Expired - Fee Related
- 1992-12-01 EP EP92923950A patent/EP0625977B1/fr not_active Expired - Lifetime
- 1992-12-02 TW TW081109648A patent/TW306921B/zh active
- 1992-12-02 MX MX9206939A patent/MX9206939A/es not_active IP Right Cessation
- 1992-12-02 IL IL103944A patent/IL103944A/xx not_active IP Right Cessation
-
1994
- 1994-06-03 FI FI942635A patent/FI942635A/fi unknown
-
1995
- 1995-06-22 HU HU95P/P00337P patent/HU211518A9/hu unknown
-
1996
- 1996-10-23 US US08/731,953 patent/US5710149A/en not_active Expired - Lifetime
-
1998
- 1998-01-23 GR GR980400158T patent/GR3025988T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9206861A (pt) | 1995-11-21 |
| MX9206939A (es) | 1993-06-01 |
| IL103944A (en) | 1997-06-10 |
| JPH07501803A (ja) | 1995-02-23 |
| GR3025988T3 (en) | 1998-04-30 |
| AU658242B2 (en) | 1995-04-06 |
| DK0625977T3 (da) | 1998-05-04 |
| KR100244626B1 (ko) | 2000-05-01 |
| DE69224212T2 (de) | 1998-04-30 |
| CA2124680C (fr) | 2004-02-17 |
| US5710149A (en) | 1998-01-20 |
| EP0625977B1 (fr) | 1998-01-21 |
| ATE162527T1 (de) | 1998-02-15 |
| IL103944A0 (en) | 1993-05-13 |
| GB2262093B (en) | 1995-06-07 |
| JP3262333B2 (ja) | 2002-03-04 |
| WO1993011122A1 (fr) | 1993-06-10 |
| HU9401686D0 (en) | 1994-09-28 |
| GB9125900D0 (en) | 1992-02-05 |
| RU94030476A (ru) | 1996-04-20 |
| TW306921B (fr) | 1997-06-01 |
| EP0625977A1 (fr) | 1994-11-30 |
| NZ246007A (en) | 1995-04-27 |
| GB2262093A (en) | 1993-06-09 |
| HU211518A9 (en) | 1995-11-28 |
| RU2125566C1 (ru) | 1999-01-27 |
| HUT70755A (en) | 1995-10-30 |
| FI942635A0 (fi) | 1994-06-03 |
| GB9225121D0 (en) | 1993-01-20 |
| DE69224212D1 (de) | 1998-02-26 |
| FI942635A (fi) | 1994-06-03 |
| AU2953792A (en) | 1993-06-28 |
| ES2111654T3 (es) | 1998-03-16 |
| CA2124680A1 (fr) | 1993-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2262093B (en) | Piperazine derivatives | |
| GB2248616B (en) | Piperazine derivatives | |
| HK1036802A1 (en) | Aminotetrazole derivatives useful as nitric oxide synthase inhibitors | |
| NO900425D0 (no) | Fremgangsmaate og anvendelse av imidazopyridaziner. | |
| GB2254324B (en) | Piperazine derivatives | |
| GR3007087T3 (fr) | ||
| DK0393534T3 (da) | Farmaceutisk virksomme pteridinderivater |